Oskie Capital Management LLC is a large investment advisory and management firm that charges performance based fees on its services. The firm has its headquarters in New York City. The SEC 13F filings of Oskie Capital Management LLC for the quarter ended September 30, 2014, showed that its three main investments are Actavis PLC (NYSE:ACT), Air Products & Chemicals, Inc. (NYSE:APD), and H & R Block Inc (NYSE:HRB).
Actavis PLC (NYSE:ACT) became the largest investment of Oskie Capital Management LLC for the third quarter 2014, having an investment value of $14.8 million. Actavis PLC (NYSE:ACT) is a specialized pharmaceutical company that develops, manufactures, and sells generic, top quality branded pharmaceutical and biosimilar products. The company is keen on acquiring Allergan, the Botox maker, for $66 billion. This shelves off the takeover efforts by Valeant Pharmaceuticals International Inc.
Air Products & Chemicals, Inc. (NYSE:APD) came second on the list with investment worth $13.3 million. Air Products & Chemicals, Inc. (NYSE:APD) is an international corporation that sells chemicals and gases in large amounts for industrial use. The company serves customers in different industries including healthcare, technology, industries, and energy sectors. The company recently declared a quarterly dividend of $0.77 per share. This represents a 2.16% dividend yield. In the latest analysis of the company, Zacks reiterated a “neutral” rating on the stock.
H & R Block Inc (NYSE:HRB) was third largest investment of Oskie Capital Management LLC, accounting for $10.9 million in investment value. H & R Block Inc (NYSE:HRB) is a company that focuses on tax preparation services, offered to different institutions and businesses globally. The company also provides several other financial services to clients through subsidiaries. A few of the subsidiaries of H & R Block Inc (NYSE:HRB) are McGladrey, Sand Canyon Corp, Block Financial LLC, H&R Block Bank, and RedGear Technologies, Inc.
This article has been written by Victor Ochieng.